Assessment of the change of antiemetic prophylaxis from double to triple combination in patients with high dose carboplatin chemotherapy.
Marta AlbanellÁngela Pérez SánchezInés Monge-EscartínGisela RiuMª Carmen Rodríguez MuesMª Lourdes Corominas BoschLydia Gaba GarcíaNeus Basté RollánNoemí ReguartDolors Soy MunerEsther Carcelero San MartínPublished in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2023)
TC showed superiority in early and delayed CINV control in carboplatin AUC ≥ 4 regimens, with no significant differences among cancer types. Change in NEPA administration timing has beneficial implications; it allows NEPA to be administered at hospitals before chemotherapy session.